138 related articles for article (PubMed ID: 15846123)
21. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
Huang X; Whitworth CA; Rybak LP
Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
[TBL] [Abstract][Full Text] [Related]
22. Protective effect of ebselen, a seleno-organic compound, against the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
Ohta Y; Kobayashi T; Inui K; Yoshino J; Nakazawa S
Jpn J Pharmacol; 2002 Dec; 90(4):295-303. PubMed ID: 12501005
[TBL] [Abstract][Full Text] [Related]
23. The effects of ebselen on cisplatin and diethyldithiocarbamate (DDC) cytotoxicity in rat hippocampal astrocytes.
Hardej D; Trombetta LD
Toxicol Lett; 2002 May; 131(3):215-26. PubMed ID: 11992741
[TBL] [Abstract][Full Text] [Related]
24. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group.
Yamaguchi T; Sano K; Takakura K; Saito I; Shinohara Y; Asano T; Yasuhara H
Stroke; 1998 Jan; 29(1):12-7. PubMed ID: 9445321
[TBL] [Abstract][Full Text] [Related]
25. [Experimental studies of the protective effect of ginkgo biloba extract (GBE) on cisplatin-induced toxicity in rats].
Fukaya H; Kanno H
Nihon Jibiinkoka Gakkai Kaiho; 1999 Jul; 102(7):907-17. PubMed ID: 10459293
[TBL] [Abstract][Full Text] [Related]
26. Oral pretreatment with ebselen enhances heat shock protein 72 expression and reduces myocardial infarct size.
Baljinnyam E; Hasebe N; Morihira M; Sumitomo K; Matsusaka T; Fujino T; Fukuzawa J; Ushikubi F; Kikuchi K
Hypertens Res; 2006 Nov; 29(11):905-13. PubMed ID: 17345791
[TBL] [Abstract][Full Text] [Related]
27. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR
Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384
[TBL] [Abstract][Full Text] [Related]
28. Vitamin E reduces cisplatin ototoxicity.
Kalkanis JG; Whitworth C; Rybak LP
Laryngoscope; 2004 Mar; 114(3):538-42. PubMed ID: 15091231
[TBL] [Abstract][Full Text] [Related]
29. Oral ethanol potentiates the loss of outer hair cells in cisplatin-exposed rats.
Madnani D; Li G; Frenz CM; Frenz DA
Otolaryngol Head Neck Surg; 2007 Aug; 137(2):327-31. PubMed ID: 17666265
[TBL] [Abstract][Full Text] [Related]
30. Effects of a single high dose of cisplatin on the melanocytes of the stria vascularis in the guinea pig.
Laurell G; Ekborn A; Viberg A; Canlon B
Audiol Neurootol; 2007; 12(3):170-8. PubMed ID: 17259704
[TBL] [Abstract][Full Text] [Related]
31. Effects of organoselenium compound 2-(5-selenocyanato-pentyl)-benzo[de]isoquinoline 1,3-dione on cisplatin induced nephrotoxicity and genotoxicity: an investigation of the influence of the compound on oxidative stress and antioxidant enzyme system.
Ghosh P; Roy SS; Chakraborty P; Ghosh S; Bhattacharya S
Biometals; 2013 Feb; 26(1):61-73. PubMed ID: 23108958
[TBL] [Abstract][Full Text] [Related]
32. Comparative intravenous toxicity of cisplatin solution and cisplatin encapsulated in long-circulating, pegylated liposomes in cynomolgus monkeys.
Working PK; Newman MS; Sullivan T; Brunner M; Podell M; Sahenk Z; Turner N
Toxicol Sci; 1998 Nov; 46(1):155-65. PubMed ID: 9928679
[TBL] [Abstract][Full Text] [Related]
33. Ebselen attenuates tobramycin-induced ototoxicity in mice.
Gu R; Longenecker RJ; Homan J; Kil J
J Cyst Fibros; 2021 Mar; 20(2):271-277. PubMed ID: 32147183
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective efficacy of ebselen, an anti-oxidant with anti-inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion.
Takasago T; Peters EE; Graham DI; Masayasu H; Macrae IM
Br J Pharmacol; 1997 Nov; 122(6):1251-6. PubMed ID: 9401794
[TBL] [Abstract][Full Text] [Related]
35. Selective GSK-3beta inhibitors attenuate the cisplatin-induced cytotoxicity of auditory cells.
Park HJ; Kim HJ; Bae GS; Seo SW; Kim DY; Jung WS; Kim MS; Song MY; Kim EK; Kwon KB; Hwang SY; Song HJ; Park CS; Park RK; Chong MS; Park SJ
Hear Res; 2009 Nov; 257(1-2):53-62. PubMed ID: 19666099
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotective effects of ebselen in traumatic brain injury model: involvement of nitric oxide and p38 mitogen-activated protein kinase signalling pathway.
Wei L; Zhang Y; Yang C; Wang Q; Zhuang Z; Sun Z
Clin Exp Pharmacol Physiol; 2014 Feb; 41(2):134-8. PubMed ID: 24131109
[TBL] [Abstract][Full Text] [Related]
37. Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs.
Yumusakhuylu AC; Yazici M; Sari M; Binnetoglu A; Kosemihal E; Akdas F; Sirvanci S; Yuksel M; Uneri C; Tutkun A
Int J Pediatr Otorhinolaryngol; 2012 Mar; 76(3):404-8. PubMed ID: 22261612
[TBL] [Abstract][Full Text] [Related]
38. A low-dose regimen of cisplatin before high-dose cisplatin potentiates ototoxicity.
Harrison RT; DeBacker JR; Bielefeld EC
Laryngoscope; 2015 Feb; 125(2):E78-83. PubMed ID: 25267530
[TBL] [Abstract][Full Text] [Related]
39. Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: antioxidant defense system.
Rybak LP; Husain K; Whitworth C; Somani SM
Toxicol Sci; 1999 Feb; 47(2):195-202. PubMed ID: 10220857
[TBL] [Abstract][Full Text] [Related]
40. Aminoguanidine reduces cisplatin ototoxicity.
Kelly TC; Whitworth CA; Husain K; Rybak LP
Hear Res; 2003 Dec; 186(1-2):10-6. PubMed ID: 14644455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
